The tumor microenvironment, including hypoxia, inflammation, and the presence of cancer stem cells, may influence drug resistance in osteosarcoma.[26] These factors may modulate P-gp expression and function, as well as other resistance mechanisms, through complex signaling pathways.[9]. This evidence concerns the gene PGP and osteosarcoma.